Turing

Clinical AI Safety Layer

Turing gives clinical AI a safety layer.

Monitor model behavior in live care workflows. Detect when AI should act, stay silent, or stop. Audit decisions. Control change.

Product Surface
Media Slot4/3

Clinical operations surface preview

Turing product overview with HOLD, ABSTAIN, and CAUTION states

Representative interface preview for guided review context.

HOLD

Stop operational use

ABSTAIN

Keep the model silent outside intended use

CAUTION

Continue with controlled investigation

Why this exists

Clinical AI is entering live operations. Silent failure is no longer acceptable.

Hospitals need visibility into post-deployment model behavior across boundaries, data shifts, drift, alert burden, and operational change. Turing turns those signals into evidence, policy outcomes, and governed next steps.

Three Decisions

Turing makes HOLD, ABSTAIN, and CAUTION operationally visible.

Each state includes traceable reason codes and explicit ownership so decisions can be reviewed, escalated, and improved.

HOLD

Stop operational use when data integrity, workflow assumptions, or model behavior crosses a safety boundary.

Operational meaning: The system should not continue in its current state until review and corrective action are complete.

Next action: Escalate to incident workflow, review evidence, and approve rollback or remediation before restart.

ABSTAIN

Keep the model silent when context is out of intended use or required signal quality is missing.

Operational meaning: No automated recommendation is emitted for this context, preserving workflow safety.

Next action: Route to defined fallback path and capture reason codes for governance review.

CAUTION

Continue operation in controlled mode while drift, alert burden, or workflow variance is investigated.

Operational meaning: The model remains active with heightened scrutiny and explicit next-step ownership.

Next action: Open drift investigation, evaluate impact, and submit a governed change proposal.

Monitoring Scope

What Turing monitors in live clinical workflows

Designed for evidence-first oversight where technical signals and operational outcomes must stay connected.

Intended use boundaries

Data integrity and mapping changes

Distribution shift and score drift

Alert burden changes

Policy outcomes and reason codes

Change history and audit evidence

Evidence-first workflow

From model event to governed action

Turing links policy, audit, and change operations so teams can act early with traceable context.

  1. Step 1

    Model event

  2. Step 2

    Policy decision

  3. Step 3

    Audit evidence

  4. Step 4

    Drift investigation

  5. Step 5

    Change proposal

  6. Step 6

    Incident or rollback path

Product Surface
Media Slot16/10

Evidence workflow preview

Turing evidence-first workflow diagram

Representative interface preview for workflow context.

Review path

Move from orientation to operational evaluation

Start with platform context, continue through the guided demo path, and align pilot scope before requesting interactive access.

Built for leadership and operators

One operating layer for governance committees and front-line owners

Turing is designed for executive review and day-to-day operational credibility in the same system.

CIO and Chief Digital

Maintain governance confidence across live clinical AI programs while reducing unmanaged operational risk.

CMIO and Clinical Informatics

Protect intended use boundaries and clinician trust with clear evidence on when models should speak or stay silent.

Quality and Risk Leaders

Strengthen traceability for policy outcomes, incident review, and post-deployment oversight.

AI Governance Committees

Review policy, drift, and change decisions through one consistent operating narrative.

Operations Leaders

Turn model-state signals into controlled actions that fit existing escalation and review workflows.

Pilot outcomes

What a six-week pilot delivers

A focused pilot creates a monitored scope, investigation baseline, and governance rhythm that leadership can evaluate with confidence.

PhaseFocusWhat it delivers
Week 0-2Setup and scope definitionDefine model scope, environment boundaries, policy thresholds, workflow owners, and evidence expectations.
Week 3-6Monitoring and investigation baselineRun live monitoring, evaluate HOLD/ABSTAIN/CAUTION outcomes, and establish investigation + change control routines.
OutcomeOperational governance baselineDeliver auditable policy history, drift/alert burden visibility, and a repeatable path for safe model change.
Evidence-first
Audit-ready
Human-governed
Built for live clinical workflows

See HOLD, ABSTAIN, and CAUTION in one guided workflow

Start in the guided demo path, review pilot structure, then request controlled interactive access when your team is ready.